A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier

Virology

Volumn 219, Issue 1, 1996, Pages 220-227

  Xiang, Zhi Quan ^a   Yang, Yiping ^a,b   Wilson, James M ^a,b   Ertl, Hildegund C J ^a  

^a WISTAR INSTITUTE   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RABIES VACCINE; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABIES; RABIES VIRUS; VACCINATION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; CYTOMEGALOVIRUS; HUMAN ADENOVIRUS; RABIES VIRUS; VACCINIA;

EID: 0029951519     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0239     Document Type: Article

References (31)

1. Brochier, B., Boulanger, D., Costy, F., and Pastoret, P.-P. (1994). Towards rabies elimination in Belgium by fox vaccination using a vaccinia-rabies glycoprotein recombinant virus. Vaccine 12, 1368-1371.
2. Burger, S. R., Remaley, A., Danley, J. M., Muschel, R. J., Wunner, W. H., and Spitalnik, S. L. (1991). Stable expression of rabies virus glycoprotein in Chinese hamster ovary cells. J. Gen. Virol. 72, 59-367.
3. Dietzschold, B. D., Tollis, M., Lafon, M., Wunner, W. H., and Koprowski, H. (1987). Mechanism of rabies virus neutralization by glycoprotein-specific monoclonal antibodies. Virology 161, 29-36.
4. Eloit, M., Gilardi-Hebenstrit, P., and Perricaudet, M. (1990). Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine. J. Gen. Virol. 71, 2425-2431.
5. Ertl, H. C. J., Dietzschold, B., Gore, M., Otvos, L., Jr., Larson, J. K., Wunner, W. H., and Koprowski, H. (1990). Induction of rabies virus-specific T-helper cells by synthetic peptides that carry dominant T-helper cell epitopes of the viral ribonucleoprotein. J. Virol. 63, 2885-2892.
6. Ertl, H. C. J., Dietzschold, B. D., and Otvos, L., Jr. (1991). T helper cell epitopes of rabies virus nucleoprotein defined by tri- and tetra-peptides. Eur. J. Immunol. 21, 1-10.
7. Ginsberg, H. S., Lundholm-Beauchamp, U., Horswood, R. L., Pernis, B., Wold, W., Chanock, R. M., and Prince, G. A. (1989). Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc. Natl. Acad. Sci. USA 86, 3823-3827.
8. Graham, F. L., Smiley, J., Russell, W. L., and Nairn, R. (1977). Characterization of a human cell line transformed by DNA from adenovirus 5. J. Gen. Virol. 36, 59-72.
9. Jaffe, H. A., Danel, G., Longenecker, G., Metzger, M., Setoguchi, Y., Rosenfeld, M. A., Gant, T. W., Thorgeirsson, S. S., Stratford-Perricaudet, L. D., Pericaudeet, M., Pavirani, A., Lecocq, J. P., and Crystal, R. G. (1992). Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet. 1, 372-378.
10. Kozarsky, K. F., and Wilson, J. M. (1993). Gene therapy: Adenovirus vectors. Curr. Opin. Genet. Dev. 3, 499-503.
11. Kozarsky, K., Grossman, M., and Wilson, J. M. (1993). Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemia. Som. Cell Mol. Genet. 19, 449-458.
12. Marrack, P., and Kappler, J. (1994). Subversion of the immune system by pathogens. Cell 76, 323-332.
13. Otvos, L., Jr., Urge, L., Xiang, Z. Q., Krivulka, G. R., Nagy, L., Szendrei, G. I., and Ertl, H. C. J. (1994). Glycosylation of synthetic T helper cell epitopic peptides influences their antigenic potency and conformation in a sugar location-specific manner. Biochim. Biophys. Acta 1224, 68-76.
14. Prevec, L., Campbell, J. B., Christie, B. S., Belbeck, L., and Graham, F. L. (1990). A recombinant human adenovirus vaccine against rabies. J. Infect. Dis. 161, 27-30.
15. Ragot, T., Finerty, S., Watkins, P. E., and Morgan, A. J. (1993). Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin. J. Gen. Virol. 74, 501-507.
16. Rosenfeld, M. A., Yoshimura, K., Trapnell, B. C., Yoneyama, K., Rosenthal, E. R., Dalemans, W., Fukayama, M., Bargon, J., Stier, J., Stratford-Perricaudet, L., Perricaudeet, M., Guggino, W. B., Pavirani, A., Lecocq, J. P., and Crystal, R. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155.
17. Subraminan, T., Kuppuswami, M., Gysbers, J., Mak, S., and Chinnadurai, G. (1983). 19 kD tumor antigen coded by early region E1b of adenovirus 2 is required for efficient synthesis and for protection of viral DNA. J. Biol. Chem. 259, 11777-11783.
18. Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Friedman, A., Hawe, L. A., Leander, K. R., Martinez, D., Perry, H. C., Shiver, J. W., Montgomery, D. L., and Liu, M. A. (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749.
19. United States Department of Agriculture, Animal and Plant Health Inspection Service (1992). "Proposed Field Trial of a Live Experimental Vaccine-Vector Recombinant Rabies Vaccine for Raccoons. New Jersey - 1992. Environmental Assessment and Finding of No Significant Impact."
20. White, E., Cipriani, R., Sabbatini, P., and Denton, A. (1991). The adenovirus E1B 19 kilo-dalton protein overcomes the cytotoxicity of E1A proteins. J. Virol. 65, 2968-2978.
21. Wiktor, T. J. (1973). Tissue culture methods. In "Laboratory Techniques in Rabies" (M. Kaplan and H. Koprowski, Eds.), 2nd ed., Vol. 23, pp. 101-120. World Health Organization Monograph, Geneva.
22. Wiktor, T. J., Dietzschold, B., Leamson, N., and Koprowski, H. (1977). Induction and biological properties of defective interfering particles of rabies virus. J. Virol. 21, 626-633.
23. Wiktor, T. J., and Koprowski, H. (1978). Monoclonal antibodies against rabies virus produced by somatic cell hybridization: Detection of antigenic variants. Proc. Natl. Acad. Sci. USA 75, 3938-3945.
24. Wiktor, T. J., MacFarlan, R. T., Reagan, K., Dietzschold, B., Curtis, P. J., Wunner, W. H., Kieny, M. P., Lathe, R., Lecocq, J. P., Mckett, M., Moss, B., and Koprowski, H. (1984). Protection from rabies by a vaccinia rabies recombinant containing the rabies virus glycoprotein gene. Proc. Natl. Acad. Sci. USA 81, 7194-7198.
25. Wilson, J. M., Engelhardt, J. F., Grossman, M., Simon, R. H., and Yang, Y. (1994). Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: A phase I trial. Hum. Gene Ther. 5, 501-519.
26. Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., and Feigner, P. L. (1990). Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468.
27. Wolff, J. A., Ludtke, J. J., Acsadi, G., Williams, P., and Jani, A. (1992). Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1, 363-369.
28. Xiang, Z. Q., and Ertl, H. C. J. (1992). Transfer of maternal antibodies results in inhibition of specific immune responses in the offspring. Virus Res. 24, 297-314.
29. Xiang, Z. Q., and Ertl, H. C. J. (1994). A simple method to test the ability of individual viral proteins to induce immune responses. J. Virol. Methods 47, 103-116.
30. Xiang, Z. Q., Spitalnik, S. L., Cheng, J., Erikson, J., Wojczyk, B., and Ertl, H. C. J. (1995). Immune responses to nucleic acid vaccines to rabies virus. Virology 209, 569-579.
31. Yang, Y., Ertl, H. C. J., and Wilson, J. M. (1994). MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1, 433-442.